0
0
1/3/23 at 8:58pm
Organization
Contagionlive.com
Author
Nina Cosdon
37 words
0
Comments
Despite failing to meet primary trial endpoints, molnupiravir reduced the length of COVID-19 infection by 4.2 days in vaccinated patients.
You are the first to view
https://www.contagionlive.com/view/molnupiravir-doesn-t-decrease-covid-19-deaths-or-hospitalizations-but-may-speed-recovery
Create an account
or login to join the discussion